Efthimia T. Leonardi, PhD
Massapequa, New York 11758
acql2n@r.postjobfree.com
Professional Experience:
President
Lucida Medical Communications
Massapequa, NY
Direction of business strategy and new business development
Dynamic leader of remote teams within and outside the US
Participation in industry-wide meetings to discuss and assess current regulatory guidelines and industry practices
Liaising with clients and internal teams both onsite and remotely to ensure client expectations for deliverables and future strategies are met
Participation in medical-legal review as required
Final approver in planning and development of core medical education deliverables across a broad range of therapeutic areas including CNS, immunology, oncology, medical diagnostic devices
oScientific communication strategies across all stages of product development
oBrand planning and lifecycle management
oStrategic publication planning
oPublication development and execution (abstracts, posters, manuscripts, monographs in peer-reviewed journals and relevant specialty medical conferences)
oPromotional strategies and materials (brochures, slide kits, videos, newsletters)
oDigital and mobile content development and management (iOS and Android apps, web-based programs)
oPatient outreach initiatives (e-newsletters, mobile applications, conference materials)
2009-2010
Editorial Team Leader
Complete Medical Communications
Parsippany, NJ
Scientific team leader across multiple therapeutic areas including oncology (e.g., breast cancer, melanoma, lung cancer), inflammatory diseases (including psoriatic arthritis), major depressive disorder, acute and chronic pain, Parkinson’s disease
Strategic and project management of assigned accounts and projects both in the US and UK while working remotely either from home-based or company offices
oScientific lead for assigned accounts
oSupervision of writers and editorial staff to ensure appropriate project delivery at all stages including resourcing to appropriate levels
Publications (posters abstracts, manuscripts) promotional materials and strategies
oMentoring of new writers
oResponsible for day-to-day management of accounts, as well as organic growth of the business
oLiaising with key opinion leaders
oProject tracking and alignment with budget
oProject tracking and alignment in accordance with client processes, including medical-legal review
Participation in industry-wide meetings to discuss and assess current regulatory guidelines and industry practices
Participation in and development of new business proposals and presentations
2007-2009
Associate Scientific Director
Discovery Chicago
Chicago, IL
Scientific lead in content development and strategic scientific communications across multiple therapeutic areas: obesity, type 2 diabetes, multiple sclerosis, cardiometabolic risk, dermatology, multiple sclerosis, pulmonary infectious disease in cystic fibrosis, cord blood stem cell preservation
oPublication planning
oNational advisory boards
oCompetitive analyses and related strategic scientific communications
oStrategic communications consulting with clients addressing multiple launch scenarios
oPromotional materials (animated videos, monographs, slide decks)
Scientific lead in promotional medical and legal review on behalf of agency
Liaised with key opinion leaders to develop content as needed
Mentoring of new hires and editorial assistants
New business development
2006-2007
Scientific Associate
McMahon Publishing Group
New York, New York
Scientific lead in content development and strategic scientific communications across multiple therapeutic areas: acute and chronic pain conditions (prescription opioids), ADHD, oncology (leukemias)
Partnering with clients and supportive personnel in the planning and execution of
o promotional materials (strategic platforms, slide kits, sales training documents) up to and
ostrategic publications
ospecial reports highlighting professional conference activities in McMahon medical news publications (CNS News, Oncology News, Pain Medicine News)
oregulatory materials (package inserts, target product profile for submission to the Food and Drug Administration)
onational advisory boards
ocontinuing medical education materials (slide kits, telecasts, monographs, digital video presentations)
Planning and development of national conference on psychiatry
Planning and development of national conference on pain management
Mentoring and supervision of new hires
2004-2006
Scientific Associate/Biomedical Writer
Phase Five Communications/Grey Healthcare Group
New York, New York
Scientific medical writing across multiple therapeutic areas
Therapeutic areas include oncology, movement disorders, urinary incontinence, migraine prevention, cell transplantation, epilepsy, hypertension
oDevelopment of scientific content for promotional and CME materials (slide kits, videos) up to and through medical-legal review where appropriate
oDevelopment of publication plans, competitive intelligence documents, gap analyses, competitive assessments
oDevelopment and submission of abstracts and manuscripts
oDevelopment and presentation of new business proposals
o Interviewing of key opinion leaders (medical experts in the field)
oPresentation of products to clients (pharmaceutical companies)
2001-2004
Adjunct Assistant Professor
New York University
Graduate School of Arts and Science
New York, New York
Development and instruction of a graduate course in neuropharmacology (Drugs and the Brain)
Mentorship and supervision of four Master of Science students
Investigation of murine and tissue culture models of movement disorders
Presentation of scientific findings to funding agencies
2000-2004
President
Pelmar Consulting, Inc
Massapequa, New York
Development of scientific content for promotional and CME materials
Development of slide kits, newsletters, abstracts for various clients
Client roster: Phase Five Communications, Sunrise Medical Laboratories, Children’s Neurobiological Solutions (CNS) Foundation
1999-2000
Instructor
The Mount Sinai School of Medicine
New York, New York
Scientific investigation of movement disorders
Lecture presentations at scientific meetings
Development of manuscripts and other publications
Successful applications for external funding of research
Instruction of residents and medical students
Presentation of scientific findings to funding agencies
1995-1999
Postdoctoral Associate
The Mount Sinai School of Medicine
New York, New York
Scientific investigation of movement disorders
Presentation of scientific findings at professional meetings
Development of manuscripts and other publications
Successful applications for external funding of research
Education:
1988-1995
Doctor of Philosophy
New York University
Graduate School of Arts and Sciences
New York, New York
Doctoral degree awarded with distinction
Investigation of the role of serotonin in the neurodegenerative mechanism of substituted amphetamines
Presentation of scientific findings at professional meetings
Instruction of graduate and undergraduate courses
1984-1986
Master of Science
New York University
Graduate School of Arts and Science
New York, New York
Majors: Cell Biology and Neuroscience
1980-1984:
Bachelor of Arts
New York University
College of Arts and Science
New York, New York
Majors: Biology and Classics
Awards:
Research Scientist Award, American Parkinson’s Disease Association (1999-2004)
Research Investigator Award, (co-investigator with C. Mytilineou), Bachmann-Strauss Parkinson’s Disease and Dystonia Foundation (1996-1999)
New York University Graduate Assistant Award (1986, 1988-1995)
New York State Regents Scholarship (1980-1984)
New York University College of Arts and Science Scholarship Award (1980-1984)
Publications:
Leonardi ET, Mytilineou C. Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease. Adv Exp Med Biol. 1998; 446:203-222.
Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen
G, Olanow CW. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity
induced by glutathione depletion. J Pharmacol Exp Ther. 1998;284:700-706.
Mytilineou C, Radcliffe P, Leonardi EK, Werner P, Olanow CW.
L-deprenyl protects mesencephalic dopamine neurons from glutamate
receptor-mediated toxicity in vitro. J Neurochem. 1997;68:33-339.
Ueda S, Kokotos Leonardi ET, Bell J 3rd, Azmitia EC.
Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 beta
antisense gene. Brain Res Mol Brain Res. 1995; 29:365-368.
Leonardi ET, Azmitia EC. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology. 1994;10:231-238.
Skills:
Working knowledge of ACCME, ICMJE, FDA and PhRMA guidelines. Facility with MSOffice programs (Powerpoint, Excel, Word), strategic platform development, publication planning, mentoring and supervision of colleagues, fluent in French and Greek.
Therapeutic areas:
1)CNS-related indications: attention deficit hyperactivity disorder, pain management, migraine, epilepsy, movement disorders, neurodegenerative disease including Parkinson’s disease, Alzheimer’s disease and multiple sclerosis
2) Immunology (rheumatoid arthritis, psoriatic arthritis, dry eye syndrome)
3)Oncology: breast cancer, nonsmall cell lung carcinoma, melanoma, chronic lymphocytic leukemia
4)Cardiovascular and metabolic conditions: diabetes, hypertension, and obesity;) 4) urology: benign prostatic hyperplasia urinary incontinence
5)Infectious disease
6)Women’s health